|View printer-friendly version|
|July 28, 2011 1:35 p.m.|
|Teva Announces Launch of CamreseTM the Authorized Generic of Seasonique ®|
JERUSALEM, Jul 28, 2011 (BUSINESS WIRE) -- Teva Pharmaceuticals USA, the U.S.-based generic arm of Teva Pharmaceuticals announced that it will sell Camrese TM as the Authorized Generic of Seasonique® which is also manufactured by Teva Pharmaceuticals. This product will continue to be manufactured under the brand product's new drug application or NDA at the same facility where it is currently produced.
"As both a brand and generic company, we realize that we must remain competitive with other potential generic versions of this product," stated Timothy Crew, head of Teva North America's Generics division. "We are proud of our Seasonique® product and the benefits we will continue to be able to offer to patients."
Teva's Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995:
SOURCE: Teva Pharmaceutical Industries Ltd.